March 23, 2015

FIT Biotech to develop animal vaccines for China

FIT Biotech is starting up co-operation with the Chinese Qyh Biotech Company.
FIT Biotech is starting up co-operation with the Chinese Qyh Biotech Company.
Tapani Mylly / Lehtikuva

The Finnish company FIT Biotech is starting up co-operation with the Chinese Qyh Biotech Company. The companies have signed an agreement concerning the development of several DNA vaccines for animals.

The vaccines are designed to improve China’s agriculture and animal husbandry, as well as the security of the food chain. The Chinese company was established to prevent and treat diseases in farm animals, in addition to which it is one of China’s largest manufacturers of animal vaccines.

“I am convinced that our partnership with FIT Biotech will present a significant turning point in our fight against animal diseases in China, both in terms of prevention and treatment,” says Qyh’s general director Dechao Qin.

The vaccines are based on the patented GTU vector technology developed by the Finnish FIT Biotech. It is used to construct particularly efficient DNA vaccines to prevent and treat infectious diseases.

Looking for more good news? Subscribe to our newsletter

Share: